Navigation Links
Pharmacopeia Announces Third Quarter 2007 Financial Results
Date:11/1/2007

e treatment of

hypertension and diabetic nephropathy. Findings from this study

also supported once-a-day oral dosing of PS433540 as the compound

successfully demonstrated its ability to block the angiotensin II-

induced blood pressure increase for 24 hours.

-- PS433540 demonstrated positive results in a multiple ascending dose

study. This safety and tolerability study was initially designed to

evaluate 14 days of daily dosing in healthy volunteers, at dose

levels of 50, 100, 250 and 500 mg of PS433540. As no safety or

tolerability issues were observed with any of these doses, the study

was expanded to include a 1,000 mg dose. As with previous lower

doses, there were no safety or tolerability issues observed with the

1,000 mg dose of PS433540.

-- Pharmacopeia announced that Bristol-Myers Squibb Company (BMS)

initiated a Phase 2 clinical trial with a p38 kinase inhibitor,

PS540446, that resulted from a collaborative research program between

the two companies. PS540446 is being evaluated for the oral treatment

of moderate to severe psoriasis.

-- Pharmacopeia announced that it earned a $1 million milestone payment

from Schering-Plough as the result of the initiation of a Phase 1

clinical trial in the United States for PS948115, a compound identified

from the collaboration between the two companies. The compound is

being evaluated as a potential treatment for respiratory disease.

Pharmacopeia is eligible to receive additional milestone payments for

PS540446 and PS948115 if the programs are advanced further in clinical

trials by BMS and Schering-Plough, respectively. The company will also

receive royalties on sales of any resulting therapeutic products

incorporating compounds derived from the progr
'/>"/>

SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... ... the addition of the  "Sugar Alcohols - ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... Sugar Alcohols in Million Pounds by the ... Cosmetics, Oral-Care Products, and Others.  , ,The ...
(Date:9/18/2014)... 2014   MacPractice,s MacPractice MD MU version ... certification, which designates that the software is capable of ... Stage 2 Meaningful Use measures required to qualify for ... MacPractice MD MU version 5.0 was certified on June ... of the National Coordinator-Authorized Certification Body (ONC-ACB) and is ...
(Date:9/18/2014)...  Casen Buswell has a rare vascular condition that causes ... is one of only 14 known cases of glomuvenous malformations ... the United States , and one of ... dual wave-length laser, is Methodist Children,s Hospital, a campus of ... a laser available in South Texas ...
Breaking Medicine Technology:Sugar Alcohols - Global Strategic Business Report 201 2Sugar Alcohols - Global Strategic Business Report 201 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2
... United Therapeutics Corporation (Nasdaq: UTHR ) announced today that ... on Thursday, April 29, 2010 . , ... United Therapeutics will host a half-hour teleconference on ...  The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533. ...
... , China , April 21 /PRNewswire-Asia/ ... SCR ), a leading pharmaceutical company,specializing in the ... in China , today announced that its,diosmectite, the ... has passed EU-GMP inspection. This enables Simcere to,market diosmectite ...
Cached Medicine Technology:Simcere's Diosmectite API Passes EU-GMP Inspection 2
(Date:9/19/2014)... the wonder material graphene has been used to detect ... , The biosensor has been shown to be ... currently in use, and was able to provide results ... of a rapid, point-of-care diagnostic tool for patients. , ... IOP Publishing,s journal 2D Materials . , To ...
(Date:9/19/2014)... September 19, 2014 The ... traditional Scandinavian style of eating, is making ... like Diet Doc’s medical weight loss ... and eating good food which leads to ... on teaching patients to understand how diet ...
(Date:9/19/2014)... September 19, 2014 Activz Whole-Food Nutrition ... Smoothie product, a new whole-food produce powder smoothie, ... Baltimore, MD. Activz Greens Smoothie is a ... one convenient – and absolutely delicious —Greens Smoothie. Details ... Baltimore, MD. , The new ...
(Date:9/19/2014)... Accident Research & Road Safety - Queensland (CARRS-Q) study ... Conference (OSIT) which is being held on the Gold ... CARRS-Q road safety researcher, said speed limit credibility was ... related traffic controls remained in place at inactive roadwork ... are asked to slow down at roadwork sites but ...
(Date:9/19/2014)... Lifeinsuranceprices.info has released a new blog post announcing ... online. , Clients who smoke or use other ... quotes from multiple providers on a single website. Insurance ... Smoking will always influence life insurance prices, in a ... for life coverage and if they have health issues, ...
Breaking Medicine News(10 mins):Health News:Graphene sensor tracks down cancer biomarkers 2Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 2Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 3Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 4Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 2Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 3Health News:Don't cry wolf: Drivers fed up with slowing down at inactive roadwork sites 2Health News:Smokers Can Compare Term Life Insurance Quotes At Lifeinsuranceprices.info! 2
... The vaccine given to children to immunise against serious ... from the Sahlgrenska Academy at the University of Gothenburg, ... tripled over the past 50 years. Each year ... result of pneumococcal disease. Worst affected are those in ...
... team, led by Mitchell Lazar, MD, PhD, director of ... Perelman School of Medicine, University of Pennsylvania, reports in ... enzyme called histone deacetylase 3 (HDAC3) was deleted had ... thus protected from glucose intolerance and insulin resistance, the ...
... , FRIDAY, May 4 (HealthDay News) -- Breast cancer in men ... may be more deadly, new research suggests. "Men with breast ... there are opportunities to improve that," said study author Dr. Jon ... to get the standard treatments that women get." Survival rates ...
... , FRIDAY, May 4 (HealthDay News) -- Patients with ... nearly half a day -- in hospital emergency departments, and ... a new study says. Overall, patients with psychiatric emergencies ... other patients, according to the findings published online May 1 ...
... By Serena Gordon HealthDay Reporter , FRIDAY, May ... perfect health can be at risk for heart disease. Just ask ... of health as a competitive swimmer. But, several weeks after a ... life. She had a condition known as infective endocarditis, which ...
... 2011 Preterm babies are born at a higher rate ... the world, including many poorer nations, according to the just-released ... Birth. The report, containing the first-ever estimates of preterm ... of Dimes Foundation, The Partnership for Maternal, Newborn & Child ...
Cached Medicine News:Health News:Pneumococcal disease: More cases but fewer deaths 2Health News:Liver fat gets a wake-up call that maintains blood sugar levels 2Health News:Men's Breast Cancer Often More Deadly, Study Suggests 2Health News:Men's Breast Cancer Often More Deadly, Study Suggests 3Health News:Psychiatric Patients Often Wait Nearly 12 Hours in ER 2Health News:A Heart Disease Veteran at Just Age 12 2Health News:A Heart Disease Veteran at Just Age 12 3Health News:New global report says US lags behind 130 other nations in preterm birth rate 2Health News:New global report says US lags behind 130 other nations in preterm birth rate 3
Intermittent catheter...
Intermittent catheter...
The SJM Sguin annuloplasty ring, a semi-rigid ring, is constructed of a one-piece solid core of ultra-high-weight polyethylene enclosed in a knitted polyester sewing cuff....
... Welcome to a new dimension ... a liquid tool composed of purified ... surgical capabilities. Perfluoron is ideal for ... vitreoretinopathy, giant retinal tears and trauma. ...
Medicine Products: